Literature DB >> 10450406

Health-related quality of life of Colles' fracture patients.

P Dolan1, D Torgerson, T K Kakarlapudi.   

Abstract

Recent guidelines published by the National Osteoporosis Foundation (NOF) make extensive use of quality-adjusted life-years (QALYs). Crucial to these guidelines, therefore, are the assumptions that are made about the health-related quality of life (HRQoL) gained from the avoidance of osteoporotic fractures. This paper reports on a study in which 50 Colles' fracture patients were asked to describe their health at each visit during treatment using the EuroQol descriptive system and to value their own health using the visual analogue scale (VAS). By applying a set of population-derived valuations to the states reported by the patients, the QALY loss is shown to be about 2%. This is about half of the loss, based upon clinician judgement, that is contained in the NOF guidelines. In addition, the results suggest that it may be possible to use VAS scores to predict treatment requirements, since those patients who require fewer visits have, on average, higher initial VAS scores.

Entities:  

Mesh:

Year:  1999        PMID: 10450406     DOI: 10.1007/s001980050136

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  27 in total

1.  Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.

Authors:  Smita Nayak; Mark S Roberts; Susan L Greenspan
Journal:  Ann Intern Med       Date:  2011-12-06       Impact factor: 25.391

2.  Influence of Cortical Comminution and Intra-articular Involvement in Distal Radius Fractures on Clinical Outcome: A Prospective Multicenter Study.

Authors:  Mats Å Wadsten; Gunnar G Buttazzoni; Göran O Sjödén; Bakir Kadum; Arkan S Sayed-Noor
Journal:  J Wrist Surg       Date:  2017-04-10

3.  Patient-reported functional outcomes and health-related quality of life following fractures of the talus.

Authors:  P Stirling; S P MacKenzie; J F Maempel; C McCann; R Ray; N D Clement; T O White; J F Keating
Journal:  Ann R Coll Surg Engl       Date:  2019-06-03       Impact factor: 1.891

4.  Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures.

Authors:  Olof Johnell; Bengt Jönsson; Linus Jönsson; Dennis Black
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

5.  Burden of non-hip, non-vertebral fractures on quality of life in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

Authors:  C Roux; A Wyman; F H Hooven; S H Gehlbach; J D Adachi; R D Chapurlat; J E Compston; C Cooper; A Díez-Pérez; S L Greenspan; A Z Lacroix; J C Netelenbos; J Pfeilschifter; M Rossini; K G Saag; P N Sambrook; S Silverman; E S Siris; N B Watts; S Boonen
Journal:  Osteoporos Int       Date:  2012-03-08       Impact factor: 4.507

6.  The risk and burden of vertebral fractures in Sweden.

Authors:  J A Kanis; O Johnell; A Oden; F Borgstrom; N Zethraeus; C De Laet; B Jonsson
Journal:  Osteoporos Int       Date:  2003-10-31       Impact factor: 4.507

Review 7.  Clinical and economic issues in the treatment of advanced breast cancer with bisphosphonates.

Authors:  Nicola Lucio Liberato; Monia Marchetti; Giovanni Barosi
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 9.  An updated systematic review of Health State Utility Values for osteoporosis related conditions.

Authors:  T Peasgood; K Herrmann; J A Kanis; J E Brazier
Journal:  Osteoporos Int       Date:  2009-03-07       Impact factor: 4.507

10.  Validation of the IOF quality of life questionnaire for patients with wrist fracture.

Authors:  P Lips; K Jameson; M L Bianchi; S Goemaere; S Boonen; J Reeve; J Stepan; O Johnell; N M van Schoor; E Dennison; J A Kanis; C Cooper
Journal:  Osteoporos Int       Date:  2009-06-06       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.